Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARHGAP20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
TIA1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CACNG6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SPRY2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
B3GNT2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZFP36L2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM84A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SENP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AGTRAP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BRWD1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CITED2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRRG4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AKAP5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
MCL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
STIM2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ATF3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CDSN - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
INSIG2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TGIF1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on